Anzeige
Mehr »
Samstag, 09.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CUPM | ISIN: US00449L1026 | Ticker-Symbol: 698
Lang & Schwarz
09.08.25 | 09:00
1,370 Euro
-100,00 % -1,370
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ACHILLES THERAPEUTICS PLC ADR Chart 1 Jahr
5-Tage-Chart
ACHILLES THERAPEUTICS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
1,3401,40009:00

Aktuelle News zur ACHILLES THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
31.03.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 31.03.2025639The following instruments on Boerse Frankfurt do have their last trading day on 31.03.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 31.03.2025.ISIN NameCA92905D1042 VORTEX...
► Artikel lesen
25.03.XFRA 698: AUSSETZUNG/SUSPENSION297DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILACHILLES THERAP.SP.ADS/1...
► Artikel lesen
25.03.XFRA 698: WIEDERAUFNAHME/RESUMPTION235FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
ACHILLES THERAPEUTICS Aktie jetzt für 0€ handeln
21.03.XFRA 698: AUSSETZUNG/SUSPENSION361DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILACHILLES THERAP.SP.ADS/1...
► Artikel lesen
21.03.Achilles Therapeutics plc - 15-12G, Securities registration termination3
20.03.Achilles Therapeutics plc - 6-K, Report of foreign issuer2
11.03.Achilles Therapeutics plc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities1
28.02.Achilles Therapeutics announces voluntary Nasdaq delisting, SEC deregistration2
28.02.Achilles Therapeutics plans to leave Nasdaq and liquidate4
28.02.Achilles Therapeutics plc - 6-K, Report of foreign issuer-
28.02.Achilles Therapeutics PLC: Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration315LONDON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) (the Company) today announced that it has formally notified The Nasdaq Stock Market LLC (Nasdaq) of its intention to...
► Artikel lesen
27.12.24Syncona: Achilles Therapeutics Announces Sale Of Technology Assets To AstraZeneca729LONDON (dpa-AFX) - Syncona said its investment Achilles Therapeutics has announced the sale of technology assets to AstraZeneca. The transaction include transferring of the commercial license...
► Artikel lesen
24.12.24Achilles Therapeutics PLC: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca565- Proprietary data and samples from TRACERx and Achilles' Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transaction - - Conclusion of Strategic Review - LONDON...
► Artikel lesen
19.11.24Achilles Therapeutics PLC: Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market215LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq")...
► Artikel lesen
14.11.24Achilles Therapeutics PLC: Achilles Therapeutics Reports Third Quarter 2024 Financial Results230- Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 - LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Achilles...
► Artikel lesen
19.09.24Achilles Therapeutics PLC: Achilles Therapeutics Announces Strategic Update448-Achilles to discontinue development of TIL-based cNeT therapy- -Cash position of $95.1 million as of June 30, 2024- -BofA Securities engaged to provide strategic financial advice- LONDON...
► Artikel lesen
14.08.24Achilles Therapeutics PLC: Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates202- Announced research collaboration with Arcturus Therapeutics to explore second-generation mRNA cancer vaccines using Achilles' AI-powered, tumor-targeting technology - - Provided interim Phase I/IIa...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1